Compare BIO-TECHNE Corp (TECH) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Xpeng Inc - ADR — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Xpeng Inc - ADR trades at $13.35 (market cap $12.96B). The key difference: Xpeng Inc - ADR is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| TECH | XPEV | |
|---|---|---|
Market Cap | $11.16B | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $72.12 | $28.07 |
52-Week Low | $43.31 | $12.09 |
Enterprise Value | $11.24B | $15.07B |
Dividend Yield | 0.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
